Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
H. Lee Moffitt Cancer Center and Research Institute
With
Nestle Health Science
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients will be recruited from the Moffitt Cancer Center Thoracic Oncology Outpatient Clinic when identified by a thoracic oncologist that the patient will undergo all of their chemoradiotherapy at Moffitt.
* Men and women ≥18 years of age.
* Diagnosed with unresectable stage IIIA or IIIB non-small cell lung cancer.
* Patients plan to undergo all cancer treatment at Moffitt Cancer Center with definitive concurrent chemotherapy and radiotherapy.
* No prior treatment of NSCLC.
* Able to provide informed consent.
* Performance status 0, 1 or 2.
* Life expectancy \>3 months.
* No esophagitis within 90 days.
You may not be if
Mental incompetence or chronic psychiatric disease.
Incarcerated individuals.
Use of antibiotics or probiotic supplements within one month of chemoradiotherapy.
Allergy to any of the components of Impact® Advanced Recovery or Boost® High Protein.
Pregnant female or breast-feeding. Any female patient \<45 years old not using appropriate contraceptive measures during the treatment.
Sepsis or active infection.
Chronic renal failure stage IV (requiring protein restriction) or stage V requiring dialysis.
Malnutrition defined as BMI \<16.
Inflammatory bowel disease (ulcerative colitis or Crohn's disease).
Severe hepatic dysfunction (baseline prothrombin time off any anticoagulation of international normalized ratio (INR) \>1.8).
Significant digestive disease with nausea, vomiting or diarrhea, NCI Grade \>1.
Use of IL-6 inhibitors (tocilizumab or siltuximab) within last 6 months.
Clareo Health | Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer
